COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
The COVIT-TRIAL study is an open-label, multicenter, randomized controlled superiority trial. The primary outcome measure is all-cause mortality within 14 days of inclusion.
